Introduction 33
Nearly 400,000 people in the United States died from a drug overdose involving a prescription or 34 illicit opioid between 1999 and 2017 (1) . This epidemic is not unique to the United States and 35 with the increasing distribution of highly potent synthetic opioids like fentanyl, it has become a 36 global public health emergency (2). Death from opioid overdose results from slow and shallow 37 breathing, also known as opioid induced respiratory depression (OIRD, 3). Like humans, 38 breathing in mice is severely depressed by opioids and this response is eliminated when the µ-39
Opioid receptor (Oprm1) is globally deleted (4). Oprm1 is broadly expressed, in both the central 40 and peripheral nervous systems, including sites that could modulate breathing such as: the 41 cerebral cortex, brainstem respiratory control centers, primary motor neurons, solitary nucleus, 42 and oxygen sensing afferents (5, 6) . Therefore, either one or multiple sites could be mediating the 43 depressive effects of opioids on breathing. 44 Indeed, multiple brain regions have been shown to independently slow breathing after 45 local injection of opioid agonists (6-9). However, all of these studies fail to definitively 46 demonstrate which of these sites are necessary and sufficient to induce OIRD for three reasons. 47
First, injection of opioid agonists or antagonists into candidate areas modulates µ-opiate 48 receptors on the cell body (post-synaptic) as well as receptors on incoming terminals (pre-49 synaptic). Second, these studies necessitate anesthetized and reduced animal preparations which 50 alters brain activity in many of the candidate Oprm1 expressing sites. And third, there is not a 51 'gold standard' definition for how breathing changes in OIRD, enabling each study to use 52 independently designed breathing metrics to measure the impact of their candidate brain site. 53
To address these limitations, we conducted the first detailed quantitative analysis of 54 OIRD and identify two key changes to the breath that drive the depressive effects of opioids. 55 normoxia, morphine depressed respiratory rate (by 50%, Fig. 1E ,F), peak inspiratory airflow (by 79 60%, Fig. 1E,F) , and minute ventilation (by 60%, Fig. 1F ). Hypercapnic breaths after saline 80 exhibited two phases, inspiration and expiration, each lasting about 50 msec. (Fig. 1G,H) . After 81 morphine, only the inspiratory phase (measured as inspiratory time, Ti) became substantially 82 longer ( Fig. 1G,H) . Additionally, hypercapnic breaths showed a new, third phase after expiration 83 that was characterized by little to no airflow (<0.6mL/sec.), and which we therefore define as a 84 pause ( Fig. 1G ). Such pauses lasted up to several hundred milliseconds ( Fig. 1I) and accounted 85 for about one-third of the average breath length (Fig. 1J) . Thus, the 50% decrease in respiratory 86 rate after morphine administration is primarily due to prolonging of Ti and pause phases, and the 87 increased prevalence of time spent in pause significantly contributes to the decrease in minute 88
ventilation. 89
Typically the length of inspiratory time is determined by a stretch-evoked feedback signal 90 from the lung which terminates inspiration (10). This reflex is represented by the correlation 91 observed between Ti and peak inspiratory airflow ( Fig. 1K ). Breaths in morphine still maintain 92 this correlation despite having a longer Ti and decreased inspiratory airflow ( Fig. 1K ). As a 93 result, morphine breaths have a similar tidal volume (TV) compared to saline control (Fig. 94 1L,M). In other words, as opioids decrease inspiratory airflow, Ti displays a compensatory 95 increase to preserve TV ( Fig. 1N, 11) . In summary, opioids cause only two primary changes to 96 the breath, namely, 1) decreased inspiratory airflow and 2) addition of a pause phase that delays 97 initiation of subsequent breaths (Fig. 1N ). These two parameters are controlled by the breathing 98 central pattern generator, the preBötzinger Complex (preBötC), in the brainstem and suggest that 99 this is a key locus affected during . 100
Indeed, the preBötC has been proposed to play a key role in OIRD since localized 101 injection of opioids results in respiratory depression and localized naloxone reverses decreased 102 breathing after administration of systemic opioids (7,15). However, such experiments fail to 103 distinguish between the action of opioids on presynaptic terminals (16) of distant neurons 104 projecting into the preBötC versus direct action on preBötC neurons themselves ( Fig. 2A 17,18) . 105
To overcome this, we genetically eliminated the µ-Opiate receptor (Oprm1) from preBötC cells 106 exclusively, sparing projecting inputs, by stereotaxic injection of adeno-associated virus 107 constitutively expressing Cre (AAV-Cre) into the preBötC of Oprm1(f/f) adult mice ( Fig. 2B) . 108
To establish a baseline, we first measured breathing after administration of saline and morphine 109 in normoxia and hypercapnia in intact animals, as described above. At least one month after 110 bilateral injection of virus into the preBötC, we then re-analyzed breathing (Fig. 2C ). With this 111 protocol, each animal's unique breathing and OIRD response serves as its own internal control, 112 which is necessary due to the variability in OIRD severity between mice ( Fig. 1F ). Deletion of 113
Oprm1 in the preBötC did not affect breathing observed after saline injection ( Fig. 2D,E) , 114
suggesting that in this context, opiates do not exert an endogenous effect. In contrast, breathing 115 was markedly less depressed by morphine administration (Fig. 2D ,E) compared to the intact 116 control state: breaths were twice as fast (3 to 6 Hz, Fig. 2F ,H), the peak inspiratory flow was 117 larger ( Fig. 2F,I) , and pauses were nearly eliminated ( Fig. 2G,J) . Notably, histological analysis 118 confirmed that AAV-Cre::GFP expression was localized to the preBötC (Fig. S1 ), and AAV-119 GFP or tdTomato injected control mice without removal of Oprm1 showed no change in OIRD 120 compared to the pre-injected control state ( Fig. 2H -J), demonstrating that animals do not develop 121 tolerance to opioids within our experimental timeline. Importantly, rescue of OIRD was also 122 specific to breathing since opioids induced analgesia in tail-flick assay after deletion of Oprm1 in 123 the preBötC (Fig. S2 ). 124
Although key features of OIRD (inspiratory airflow and pause) were attenuated by 125 preBötC AAV-Cre injection, rescue was incomplete. This could be explained by incomplete 126
Oprm1 deletion within the preBötC, or participation of another brain site in OIRD. Injection of 127 opioids into the parabrachial (PBN)/Kolliker-Fuse (KF) nucleus can also slow breathing, making 128 it a candidate second site (8, 9) . In fact, the PBN/KF has been proposed to be the key site 129 mediating OIRD (19,20). We therefore took a similar approach to test the role of the PBN/KF in 130 OIRD ( Fig. 3A ). AAV-Cre injection into the PBN/KF (Fig. S3 ) produced a slight increase in the 131 morphine-evoked respiratory rate ( Fig.S4, Fig. 3D ,E) and inspiratory airflow ( Fig. S4, Fig.  132 3F,G), but had a more moderate effect than injection into the preBötC. 133
To determine if the preBötC and PBN/KF can completely account for OIRD ( Fig. 3A) , 134
we genetically deleted Oprm1 from the preBötC and then from the PBN/KF (Cohort 1) or vice 135 versa (Cohort 2, Fig. 3B ). In either cohort, double deletion breathing after morphine 136 administration looked nearly identical to that of saline control animals ( cognate cohort. To our surprise, rescues also occurred in animals with mostly unilateral PBN/KF 141 AAV-cre injection ( Fig. S5 ), therefore these animals were still included in our double deletion 142 analysis ( Fig. 3E ,G). Breathing in double-deleted animals was even resilient to super-saturating 143 doses of opioid (150mg/kg fentanyl) that severely slow breathing in control animals ( Fig. 3H,I) . 144
Taken together, our data are consistent with a model in which both the preBötC and PBN/KF 145 contribute to opioid respiratory depression, with the former being predominant, and together 146 account for OIRD. 147
Given the relative importance of the preBötC to OIRD, we sought to identify which 148
Oprm1 expressing cells within this region depress breathing. Single cell transcriptome profiling 149 of the ventral lateral brainstem of P0 mice ( Fig. 4A ) showed that Oprm1 (mRNA) is expressed 150 almost exclusively by neurons ( Fig. S6 ) and is remarkably restricted to just 8% of presumed 151 preBötC neurons (Fig. 4B ). This alone is interesting, as it suggests that modulation of only a 152 small subset of neurons with the preBötC is enough to significantly impact its ability to generate 153 a rhythm. We also determined that within the preBötC, Oprm1 (mRNA) was expressed by 154 glycinergic, gabaergic, and glutamatergic neural types alike ( Fig. 4C ) and therefore Oprm1 155 (mRNA) expression is not exclusive to any known rhythmogenic preBötC subpopulation. Cre;Oprm1(f/f)) and measured preBötC slice activity at increasing concentrations of DAMGO, 178 exceeding the dose necessary to silence the control rhythm (500nM vs. 50nM). Elimination of 179
Oprm1 from both genotypes was sufficient to rescue the frequency and amplitude of preBötC 180 bursting in DAMGO, and the Dbx1 rescue was comparable to elimination of Oprm1 from all 181 glutamatergic neurons, while the Foxp2 rescue was substantial, but partial (~50-60%, Fig. 4J ). 182
This shows that opioids silence a small cohort (~140) of glutamatergic neurons to depress 183 preBötC activity, and that a molecularly defined subpopulation, about half, can be targeted to 184 rescue these effects. 185 186
Discussion 187
Here we show that two small brainstem sites are sufficient to rescue opioid induced respiratory 188 depression. Between them, the preBötC is the critical site and we molecularly define ~140 189
Oprm1 glutamatergic neurons within that are responsible for this effect. Future study of these 190 neurons will provide the first example of endogenous opiate modulation of breathing. 191 Furthermore, characterization of these neurons and their molecular response to opioids may 192 reveal a strategy for separating respiratory depression from analgesia and therefore enable the 193 development of novel opioids or related compounds that relieve pain without risk of overdose. 194
195

A rubric for studying opioid and other respiratory depressants 196
We find that although multiple breathing parameters are impacted by opioids, decreased 197 inspiratory airflow and delayed breath initiation, which we term pause, represent the primary 198 changes that result in OIRD. The force and timing of inspiration are ultimately determined by the 199 inspiratory rhythm generator, the preBötC, and focused our initial studies to this site. From here 200 on, these two changes in the breath can act as a 'gold standard' for OIRD and should guide 201 future studies charactering and testing novel opioid drugs. Additionally, this workflow can be 202
applied to the analysis of other respiratory depressants. 203 204
Just two small brainstem sites mediate OIRD 205
Our experimental design allowed us to determine that both the preBötC and KF/PBN have 206 independent and additive rescue of OIRD. Of these two, the preBötC has the larger magnitude 207 rescue of our two core breathing parameters. The combined deletion of µ-Opiate receptor from 208 both sites essentially eliminates OIRD, even to extremely high doses of the potent opioid 209 fentanyl. This suggests that targeting just these two sites is sufficient to rescue opioid respiratory 210 depression. We interpret the small remaining effect of opioids to be due to incomplete 211 transduction of these brain areas but cannot rule out one or more other minor contributing sites. 212 213
Depression of preBötC rhythm by silencing a small glutamatergic subpopulation
The two hallmark changes during OIRD, decreased inspiratory airflow and delayed initiation, 215 perfectly match the opioid induced depression of amplitude and frequency in the preBötC slice. 216
We show that ~140 Oprm1 glutamatergic preBötC neurons mediate this effect. And surprisingly, 217 half this number, just ~70 glutamatergic neurons are sufficient to rescue opioid depression of the 218 Fig. S8 ). Further, 219
given the importance of Dbx1 neurons in respiratory rhythm generation (22,23), rescuing Oprm1 220 in just ~50/140 Dbx1 neurons (the Foxp2+ subset) may be sufficient to prevent preBötC 221 depression, the smallest number of neurons we propose. This small number is remarkably 222 consistent with the number of Dbx1 neurons that must be lesioned to arrest preBötC activity 223 (25). Given the similarity of these effects, we hypothesize that opioids are primarily acting by 224 silencing presynaptic release, effectively removing these neurons from the network. It is 225 profound that such a small number can abruptly halt the respiratory rhythm in a network of more 226 than 1000 neurons. This suggests that either these neurons act as a key population for 227 rhythmogenesis, or that recurrent excitatory networks are exquisitely sensitive to the number of 228 participating cells. 229
While this manuscript was in preparation a paper appeared that presents some findings 230 similar to ours (26). 231 232
Materials and Methods 234
Animals 235 were performed in accordance with national and institutional guidelines with standard 242 precautions to minimize animal stress and the number of animals used in each experiment. 243
Recombinant viruses 244
All viral procedures followed the Biosafety Guidelines approved by the University of California, 245
San Francisco (UCSF) Institutional Animal Care and Use Program (IACUC) and Institutional 246
Biosafety Committee (IBC). The following viruses were used: AAV5-CMV-Cre-GFP 247 (4.7x10 19 particles/mL, The Vector Core at the University of North Carolina at Chapel Hill), 248 AAV5-CAG-GFP (1.0x10 13 particles/mL, The Vector Core at the University of North Carolina 249 at Chapel Hill) or AAV5-CAG-tdtomato (4.3x10 12 particles/mL, The Vector Core at the 250
University of North Carolina at Chapel Hill). 251
Immunostaining 252
Postnatal day 0-4 brains were dissected in cold PBS, and adult brains were perfused with cold 253 PBS and then 4% paraformaldehyde by intracardiac perfusion. The isolated brains from neonates 254 and adults were then fixed in 4% paraformaldehyde overnight at 4°C and dehydrated in 30% 255 sucrose the next 24 hrs at 4°C. Brains were embedded and frozen in OCT once equilibrated in 256 Plethysmography, respiratory and behavioral analysis 274 morphine (20mg/kg) and placed in an isolated recovery cage for 15 minutes to allow full onset of 276 action of the drug. Individual mice were then monitored in a 450 mL whole animal 277 plethysmography chamber at room temperature (22°C) in 21% O2 balanced with N2 (normoxia) 278 or 21% O2, 5% CO2 balanced with N2 (hypercapnia). For fentanyl (150mg/kg) onset of action 279 was so fast (<10sec) that animals were placed directly in the plethysmography chamber after 280 administration of drug. Each session (combination of drug and oxygen condition) was separated 281 by at least 24 hours to allow full recovery. Breathing was monitored by plethysmography, and 282 other activity in the chamber monitored by video recording, for 40-minute periods in normoxia 283 and 10-minute periods in hypercapnia. In cases where mice were subject to single or double site 284 AAV injection to delete Oprm1 or sham controls, breathing was recorded first before viral 285 injection and then again after deletion (or sham) more than 4 weeks later. Breathing traces were 286 collected using EMKA iOX2 software and exported to Matlab for analysis. Each breath was 287 automatically segmented based on airflow crossing zero as well as quality control metrics. 288
Respiratory parameters (e.g. peak inspiratory flow, instantaneous frequency, pause length, tidal 289 volume, etc) for each breath, as well as averages across states, were then calculated. 290
Instantaneous frequency was defined as the inverse of breath duration. Pause length was defined 291 as the expiratory period after airflow dropped below 0.6 ml/sec. Other respiratory parameters 292 were defined by when airflow crosses the value of 0, with positive to negative being inspiration 293 onset and negative to positive being expiration onset. 294
Due to limitations in breeding, a power calculation was not explicitly performed before 295 our studies. Studies were conducted on all mice generated; six cohorts of animals. After 296 respiration was measured, mice were sacrificed and injection sites were validated before 297 inclusion of the data for further statistical analysis. We used either paired Student's t-test or 298
Wilcox Rank Sum test to evaluate statistical significance in comparisons of average (across 299 breaths) pre-and post-morphine respiratory parameters (e.g., peak inspiratory flow, 300 instantaneous frequency), based on the normality of their distributions as defined by Shapiro-301
Wilk test. In comparisons of intact vs. Oprm1-deleted or intact vs. Sham conditions the same 302 tests as above were used to evaluate statistical significance between normalized 303 (morphine/saline, or morphine-saline) respiratory parameters. Normality in this case was 304 determined by Shapiro-Wilk test on the normalized respiratory parameters. All statistics were 305 performed using the publicly available Excel package: Real Statistics Functions. 306
Tail flick assays 307
Mice were injected with saline (control trials) or 20mg/kg morphine. 15-minutes later mice were 308 put into a restraining wire mesh with the tail exposed. One-third of the tail was dipped into a 48-309 50°C water bath and time was measured for the tail to flick. Immediately after the flick, the tail 310 was removed from the bath. If the tail did not flick within 10-seconds, then the tail was removed. 311
The procedure was video recorded so time to response could be quantified post-hoc. Each mouse 312 was recorded for two saline and two morphine trials. 313
Stereotaxic injection 314
Stereotaxic injections were performed in mice anaesthetized by isoflurane. Coordinates used for 315 the preBötC were: -6.75 mm posterior, -5.05 mm ventral from surface, ±1.3 mm lateral from 316 bregma. Coordinates used for the PBN/KF were: -5.05 mm posterior, -3.7 ventral from surface, 317 ±1.7 lateral from bregma. Injection sites were confirmed by the restricted expression of Cre-GFP, GFP, or tdTomato in the anatomically defined Parabrachial/Kolliker-Fuse (35) and 319 preBötC (12,13) areas. In the case of preBötC injections, anatomical location of injection site 320 was also confirmed by localization with Somatostatin antibody staining (36). After injection of 321 the virus, mice recovered for at least 3-4 weeks before breathing metrics were recorded again. In 322 a subset of animals, mice were then subject to a second site deletion of the complementary brain 323 area, ie. preBötC and then from the PBN/KF (Cohort 1) or vice versa (Cohort 2). These mice 324
were then allowed to recover for another period of at least 3-4 weeks, after which a third set of 325 breathing metrics were recorded. 326
Slice electrophysiology 327
Rhythmic 550 to 650µm-thick transverse medullary slices which contain the preBötC and cranial 328
Oprm1(f/f);Glyt2-Cre+/-, Oprm1(f/f;)Vgat-Cre+/-, Oprm1(f/f);Dbx1-Cre+/-, Oprm1(f/f);Foxp2-330
Cre+/-(P0-5) were prepared as described (37). Briefly, slices were cut in ACSF containing (in 331 mM): 124 NaCl, 3 KCl, 1.5 CaCl 2 , 1 MgSO 4 , 25 NaHCO 3 , 0.5 NaH 2 PO 4 , and 30 D-glucose, 332 equilibrated with 95% O 2 and 5% CO 2 (4°C, pH=7.4). The rostral portion of the slice was taken 333 once the compact nucleus ambiguus was visualized. The dorsal side of each slice containing the 334 closing of the 4 th ventricle. For recordings, slices were incubated with ACSF from above and the 335 extracellular K + was raised to 9 mM and temperature to 27°C. Slices equilibrated for 20 min 336 before experiments were started. The preBötC neural activity was recorded from either XIIn 337 rootlet or as population activity directly from the XII motor nucleus using suction electrodes. 338
Activity was recorded with a MultiClamp700A or B using pClamp9 at 10000 Hz and low/high 339 pass filtered at 3/400Hz. After equilibration, 20min. of baseline activity was collected and then increasing concentrations of DAMGO (ab120674) were bath applied (20nM, 50nM, 100nM, 341 500nM). Activity was recorded for 20min. after each DAMGO application. After the rhythm was 342 eliminated or 500nM DAMGO was reached, 100nM Naloxone (Sigma Aldrich N7758) was bath 343 applied to demonstrate slice viability. Rhythmic activity was normalized to the first control 344 recording for dose response curves. 345
Single Cell mRNA Sequencing and analysis 346 650 µm-thick medullary slices containing the preBötC were prepared from 10 P0 mice C57Bl/6 347 mice as described above. The preBötC and surrounding tissue was punched out of each slice with 348 a P200 pipette tip and incubated in bubbled ACSF containing 1mg/ml pronase for 30 minutes at 349 37°C with intermittent movement. Digested tissue was centrifuged at 800rpm for 1 minute, and 350 the supernatant was discarded and replaced with 1% FBS in bubbled ACSF. The cell suspension 351 was triturated serially with fire-polished pipettes with ~600µm, ~300µm and ~150µm diameter. Factor Expression. Cell Rep, 15, 1930 Rep, 15, -1944 Rep, 15, (2016 . Respir Physiol Neurobiol, 143, 105-114 (2004) . expiration, or pause for hypercapnic breaths after saline or morphine injection. K, Scatterplot of 526 inspiratory time (msec.) vs. peak inspiratory airflow (mL/sec.) for 10-minutes of hypercapnic 527 breaths after saline (black) or morphine (red) IP injection. As inspiratory time increases, peak 528 inspiratory flow decreases. L, Scatterplot of tidal volume (µL.) vs. peak inspiratory airflow 529 (mL/sec.) for 10-minutes of hypercapnic breaths after saline (black) or morphine (red) IP 530 injection. Even though peak inspiratory airflow decreases after morphine, tidal volume is 531 preserved due to prolonged Ti. M, Ratio of tidal volume after IP injection of morphine-to-saline 532 for n = 29 animals in hypercapnia (p-value=3x10 -6 , Cohen's d=1.13). N, Schematic of the two 533 key morphine induced changes to the breath: decreased inspiratory airflow and pause. Decreased 534 inspiratory airflow prolongs Ti since negative feedback from the lung reflecting breath volume is 535 slower. We interpret the pause as a delay in initiation of the subsequent inspiration. 536 Representative examples of the breathing airflow (mL/sec.) in hypercapnia for an animal in 575 cohort 1 after saline (black) or morphine (red) before either viral injection and after both 576 
